A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

被引:0
作者
Jia, Zhenyi [1 ]
Yang, Jun [1 ]
Qin, Huanlong [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Gen Surg, Shanghai, Peoples R China
[2] Tongji Univ, Dept Gen Surg, Shanghai Peoples Hosp 10, Shanghai, Peoples R China
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2019年 / 151期
关键词
Medicine; Issue; 151; Parenteral nutrition; soybean oil; triple-chamber bags; compounded bags; olive oil; efficacy; lipids; oxidative stress; LIPID EMULSIONS; DESIGN; ISSUES;
D O I
10.3791/57956
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Limited evidence exists to precisely estimate efficacy and safety differences between parenteral nutrition (PN) prepared using olive-oil-based three-chamber bags (3CBs) and soybean-oil-based compounded bags (CoBs) in hospitalized adult patients. We designed a multicenter, randomized, prospective, open-label, noninferiority protocol to compare the efficacy, safety, and distribution of olive-oil-based 3CBs and soybean-oil-based CoB formulations in adult Chinese patients requiring PN during surgical intervention. Subjects were randomized to receive either one of the study treatments using an interactive voice or web-based recognition system in accordance with the randomization code. Randomization was further stratified based on the study site and surgical category. Both treatment groups received similar amounts of calories and protein. In addition, the two study treatments contained a similar composition of the amino-acid component. The only difference between the two PN formulations was the lipid constitution. The duration of administration of study treatments was a minimum of 5 days up to a maximum of 14 days after the surgical procedure. The primary efficacy endpoint was serum prealbumin levels on day 5 of the study. Noninferiority was proved if the anti-log of the lower bound of the 95% confidence interval (CI) of the treatment difference was at least 0.80. Other efficacy measures included treatment preparation time; duration to achieve tolerability of oral nutrition; associated infectious complications; length of hospitalization; and laboratory assessment of markers of nutrition, inflammation, metabolism, and oxidative stress. A total of 458 patients were enrolled in the study. The results showed that olive-oil-based 3CBs were non-inferior to soybean-based CoBs, besides being well tolerated. The infection rate was found to be significantly lower in the olive-oil-based 3CB group. Thus, this study may be used as a reference for future research on lipid emulsion and 3CBs.
引用
收藏
页数:11
相关论文
共 14 条
  • [1] Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions
    Calder, Philip C.
    Jensen, Gordon L.
    Koletzko, Berthold V.
    Singer, Pierre
    Wanten, Geert J. A.
    [J]. INTENSIVE CARE MEDICINE, 2010, 36 (05) : 735 - 749
  • [2] Blocked Randomization with Randomly Selected Block Sizes
    Efird, Jimmy
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2011, 8 (01) : 15 - 20
  • [3] Clinical trial design issues: At least 10 things you should look for in clinical trials
    Glasser, Stephen P.
    Howard, George
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (10) : 1106 - 1115
  • [4] Parenteral nutrition in the intensive care unit
    Jeejeebhoy, Khursheed N.
    [J]. NUTRITION REVIEWS, 2012, 70 (11) : 623 - 630
  • [5] Safety and efficacy of an olive oil-based triple-chamber bag for parenteral nutrition: a prospective, randomized, multi-center clinical trial in China
    Jia, Zhen-Yi
    Yang, Jun
    Xia, Yang
    Tong, Da-Nian
    Zaloga, Gary P.
    Qin, Huan-Long
    [J]. NUTRITION JOURNAL, 2015, 14
  • [6] Rationale for a non-inferiority clinical trial design focused on subpopulations
    Kulkarni, PM
    Meadows, ES
    Ahuja, S
    Muram, D
    Plouffe, L
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (10) : 1641 - 1647
  • [7] Challenging Issues in Clinical Trial Design Part 4 of a 4-Part Series on Statistics for Clinical Trials
    Pocock, Stuart J.
    Clayton, Tim C.
    Stone, Gregg W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (25) : 2886 - 2898
  • [8] Ruikar Vrishabhsagar, 2016, Perspect Clin Res, V7, P15, DOI 10.4103/2229-3485.173781
  • [9] Standardised Parenteral Nutrition
    Simmer, Karen
    Rakshasbhuvankar, Abhijeet
    Deshpande, Girish
    [J]. NUTRIENTS, 2013, 5 (04): : 1058 - 1070
  • [10] ESPEN Guidelines on Parenteral Nutrition: Intensive care
    Singer, Pierre
    Berger, Mette M.
    Van den Berghe, Greet
    Biolo, Gianni
    Calder, Philip
    Forbes, Alastair
    Griffiths, Richard
    Kreyman, Georg
    Leverve, Xavier
    Pichard, Claude
    [J]. CLINICAL NUTRITION, 2009, 28 (04) : 387 - 400